TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26903147

Group type: EXPERIMENTAL
Intervention: Twice-weekly intensive aerobic exercise for 12 weeks (60 minutes per session, intensity up to exertion level 14 or 15 on the Borg scale)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Twice-weekly intensive aerobic exercise for 12 weeks
Number of subjects: 56
Study: 24564888

Group type: EXPERIMENTAL
Intervention: shRNA knockdown of WNT5B (shWNT5B)
Number of subjects: 0

Group type: COMPARATOR
Intervention: WNT5B overexpression
Number of subjects: 0
Study: 23067272

Group type: EXPERIMENTAL
Intervention: Internet based smoking cessation intervention
Number of subjects: 0
Study: 19761492

Group type: EXPERIMENTAL
Intervention: Prucalopride, a selective 5-HT(4) agonist given orally once daily for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18562740

Group type: EXPERIMENTAL
Intervention: 20 mg of bisacodyl
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 30 mg of bisacodyl
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 20 mg of bisacodyl and 8.2 g of magnesium citrate
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 30 mg of bisacodyl and 16.4 g of magnesium citrate
Number of subjects: 40

Group type: COMPARATOR
Intervention: Group 2 (30 mg of bisacodyl)
Number of subjects: 40
Study: 16447661

Group type: EXPERIMENTAL
Intervention: Brain-resuscitation acupuncture method
Number of subjects: 90

Group type: COMPARATOR
Intervention: Fluoxetine (oral medication)
Number of subjects: 90
Study: 11810086

Group type: EXPERIMENTAL
Intervention: Concurrent oxytocin with sustained-release dinoprostone insert (immediate group)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Oxytocin after removal of the dinoprostone insert (delayed group)
Number of subjects: 71
Study: 10522600

Group type: EXPERIMENTAL
Intervention: Fish oil
Number of subjects: 7

Group type: COMPARATOR
Intervention: Trioleate
Number of subjects: 7
Study: 7582225

Group type: EXPERIMENTAL
Intervention: Manual placental removal with exteriorized uterine repair (group 4)
Number of subjects: 284

Group type: COMPARATOR
Intervention: Spontaneous placental removal and in situ uterine repair (group 1)
Number of subjects: 284

Group type: COMPARATOR
Intervention: Spontaneous placental removal and exteriorized uterine repair (group 2)
Number of subjects: 284

Group type: COMPARATOR
Intervention: Manual placental removal and in situ uterine repair (group 3)
Number of subjects: 284
Study: 1791685

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba extract (EGb 761) 160 mg/day
Number of subjects: 24

Group type: COMPARATOR
Intervention: Ginkgo biloba extract (EGb 761) 80 mg/day
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Assessment by doctors and patients
Number of subjects: 24
Study: 6814568

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Pindolol
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Slow-release Propranolol
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Atenolol and Slow-release Propranolol
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Metoprolol and Pindolol
Number of subjects: 34
Study: 30837427

Group type: EXPERIMENTAL
Intervention: MTHFR gene variation (677T and 1298A)
Number of subjects: 466

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 466

Group type: EXPERIMENTAL
Intervention: Sex (male vs female)
Number of subjects: 466
Study: 29295825

Group type: EXPERIMENTAL
Intervention: Intravenous belimumab 10 mg/kg plus standard of care (SoC) every 4 weeks until Week 48
Number of subjects: 677

Group type: COMPARATOR
Intervention: Placebo plus standard of care (SoC) every 4 weeks until Week 48
Number of subjects: 677
Study: 27460635

Group type: EXPERIMENTAL
Intervention: Normobaric hypoxia at 9.8% FIO2
Number of subjects: 10
Study: 25409961

Group type: COMPARATOR
Intervention: Gcontrol: conventional respiratory physiotherapy
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Gintra: PEEP at 10 cmH2O during surgery
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Gpre: BiPAP before surgery for one hour
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Gpos: BiPAP after surgery for one hour
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: All treatment groups (Gpre, Gintra, Gpos)
Number of subjects: 40
Study: 22385023

Group type: EXPERIMENTAL
Intervention: Traditional Chinese acupuncture (TCA) weekly sessions for 5 weeks
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Attention only weekly sessions for 5 weeks
Number of subjects: 18

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 18
Study: 20082362

Group type: COMPARATOR
Intervention: Minimum effective dose estimation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonlinear mixed effects models
Number of subjects: 0

Group type: COMPARATOR
Intervention: Model selection step
Number of subjects: 0
Study: 17646754

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (5-FU)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: mitomycin C (MMC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antifibrotic agents (general)
Number of subjects: 0
Study: 16134316

Group type: EXPERIMENTAL
Intervention: Modified technique with X-ray tube voltage lowered to 53 kV
Number of subjects: 44

Group type: COMPARATOR
Intervention: Standard technique with X-ray tube voltage at 69 kV
Number of subjects: 44
Study: 12065553

Group type: EXPERIMENTAL
Intervention: Maintenance therapy (MT) consisting of mercaptopurine and cytarabine for 18 months
Number of subjects: 268

Group type: COMPARATOR
Intervention: No maintenance therapy (MT)
Number of subjects: 268
Study: 9452837

Group type: EXPERIMENTAL
Intervention: Intermittent plantar compression
Number of subjects: 124

Group type: COMPARATOR
Intervention: Sequential-gradient calf compression
Number of subjects: 124
Study: 8542542

Group type: EXPERIMENTAL
Intervention: New method for determining ejection fraction by Doppler echocardiography
Number of subjects: 114

Group type: COMPARATOR
Intervention: Quinones method and single plane area length methods
Number of subjects: 114

Group type: COMPARATOR
Intervention: Single plane multiple disc method
Number of subjects: 114

Group type: COMPARATOR
Intervention: Quinones method
Number of subjects: 114

Group type: COMPARATOR
Intervention: Single plane planimetry
Number of subjects: 114
Study: 2090773

Group type: EXPERIMENTAL
Intervention: Lorazepam 2.5 mg orally prior to chemotherapy and repeated after 12 hours (Arm A)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo (Arm B)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Lorazepam (Arm A)
Number of subjects: 53
Study: 626712

Group type: EXPERIMENTAL
Intervention: Oral administration of 8‐methoxypsoralen followed by high‐intensity longwave ultraviolet treatment
Number of subjects: 15

Group type: COMPARATOR
Intervention: Conventional ultraviolet light therapy
Number of subjects: 15

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 15
Study: 30793642

Group type: EXPERIMENTAL
Intervention: Anifrolumab 100 mg IV
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Anifrolumab 300 mg IV
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Anifrolumab 1000 mg IV
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Anifrolumab
Number of subjects: 20
Study: 31270429

Group type: EXPERIMENTAL
Intervention: Educational programme on responsive feeding from birth to 24 months
Number of subjects: 468
Study: 27611637

Group type: EXPERIMENTAL
Intervention: Inhaled sevoflurane for 48 hours
Number of subjects: 50

Group type: COMPARATOR
Intervention: Midazolam for 48 hours
Number of subjects: 50
Study: 26293212

Group type: EXPERIMENTAL
Intervention: Ivabradine
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Bisoprolol
Number of subjects: 59
Study: 23578606

Group type: EXPERIMENTAL
Intervention: HPβCD-diclofenac 37.5 mg
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: HPβCD-diclofenac 75 mg
Number of subjects: 70

Group type: COMPARATOR
Intervention: Moxifloxacin (active control)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo (inactive vehicle)
Number of subjects: 70
Study: 20681817

Group type: EXPERIMENTAL
Intervention: Non-surgical periodontal therapy (including oral hygiene instructions, scaling and root planing, and systemic antibiotic therapy)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (conventional treatment)
Number of subjects: 30
Study: 19258557

Group type: EXPERIMENTAL
Intervention: Oral vitamin K, 1.25 mg
Number of subjects: 724

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 724
Study: 17114017

Group type: EXPERIMENTAL
Intervention: Laparoscopic Nissen fundoplication
Number of subjects: 183

Group type: COMPARATOR
Intervention: Proton pump inhibitor (PPI) therapy
Number of subjects: 183
Study: 15561384

Group type: EXPERIMENTAL
Intervention: Electro-acupuncture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Skin non-penetrating placebo-acupuncture (Control)
Number of subjects: 0
Study: 11281051

Group type: EXPERIMENTAL
Intervention: Second dose thiopentone (4 mg.kg‐1) administered just before laryngoscopy and intubation
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (thiopentone 4 mg.kg‐1 for induction, suxamethonium 1.5 mg.kg‐1 for muscle relaxation)
Number of subjects: 76
Study: 11050785

Group type: EXPERIMENTAL
Intervention: Morbidity register inclusion
Number of subjects: 1979

Group type: EXPERIMENTAL
Intervention: Relevant surgery contact since diagnosis
Number of subjects: 1979

Group type: EXPERIMENTAL
Intervention: Relevant repeat prescription since diagnosis
Number of subjects: 1979

Group type: EXPERIMENTAL
Intervention: Diagnosis of myocardial infarction
Number of subjects: 1979

Group type: EXPERIMENTAL
Intervention: Revascularisation procedure
Number of subjects: 1979

Group type: EXPERIMENTAL
Intervention: Adequate assessment (smoking status, blood pressure, cholesterol)
Number of subjects: 1979

Group type: EXPERIMENTAL
Intervention: Treatment with aspirin or a lipid-lowering agent
Number of subjects: 1979
Study: 8790170

Group type: EXPERIMENTAL
Intervention: Antiseptic CVC with silver sulfadiazine and chlorhexidine gluconate
Number of subjects: 72

Group type: COMPARATOR
Intervention: Standard CVC without antiseptics
Number of subjects: 72
Study: 1536941

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (IC) with VAD regimen (vincristine, doxorubicin, dexamethasone) or VMCP regimen (vincristine, melphalan, cyclophosphamide, prednisone)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: High-dose melphalan with total body irradiation supported by unpurged autologous bone marrow transplantation (ABMT)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Interferon (IFN) alpha maintenance treatment
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Post-ABMT probability of progression-free survival
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Post-diagnosis probability of survival
Number of subjects: 35
Study: 6655706

Group type: EXPERIMENTAL
Intervention: Treatment for couples not divorced or given additional therapy
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Couples who separated
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Couples given additional therapy
Number of subjects: 140
Study: 31006959

Group type: EXPERIMENTAL
Intervention: Speech-based algorithm using 18 speech features
Number of subjects: 129

Group type: COMPARATOR
Intervention: Controls (non-PTSD veterans)
Number of subjects: 129
Study: 30053899

Group type: EXPERIMENTAL
Intervention: Moxa floss from Qichun County, Hubei Province, China
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Moxa floss from Nanyang County, Henan Province
Number of subjects: 350

Group type: COMPARATOR
Intervention: Non-moxa floss (sham moxibustion)
Number of subjects: 350
Study: 25716957

Group type: EXPERIMENTAL
Intervention: Electromagnetic shielding (verum)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Visually identical placebo liners (placebo)
Number of subjects: 20
Study: 25229556

Group type: EXPERIMENTAL
Intervention: Concentric electrode with 4 Hz low frequency stimulation (LFS)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Matrix electrode with 4 Hz low frequency stimulation (LFS)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Matrix electrode with 30 Hz (sham condition)
Number of subjects: 16
Study: 23201764

Group type: EXPERIMENTAL
Intervention: Implementation intention instructions
Number of subjects: 171

Group type: COMPARATOR
Intervention: No implementation intention instructions (Control)
Number of subjects: 171
Study: 20082586

Group type: EXPERIMENTAL
Intervention: Repaglinide (2 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Nateglinide (120 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no diabetes)
Number of subjects: 20
Study: 17655982

Group type: EXPERIMENTAL
Intervention: Fortified mother's milk (FMM) with individualized supplementation of minerals and protein
Number of subjects: 120

Group type: COMPARATOR
Intervention: Preterm formula milk (PF)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Fortified mother's milk (FMM)
Number of subjects: 120
Study: 15765257

Group type: EXPERIMENTAL
Intervention: Pergolide (mixed D1/D2 agonist)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Bromocriptine (D2 selective agonist)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 12233877

Group type: EXPERIMENTAL
Intervention: Anti-TNF-α therapy
Number of subjects: 175

Group type: COMPARATOR
Intervention: GG genotype prevalence
Number of subjects: 175
Study: 9817404

Group type: EXPERIMENTAL
Intervention: 24-hour methylprednisolone (24MP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 48-hour methylprednisolone (48MP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 48-hour tirilazad mesylate (48TM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 8929934

Group type: EXPERIMENTAL
Intervention: High attendance or Enhanced Care group (average of 4.1 treatment days per week)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low attendance or Usual Care and Medium attendance groups (less than one treatment day per week)
Number of subjects: 0
Study: 2781424

Group type: EXPERIMENTAL
Intervention: Naloxone 4 mg
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 30575978

Group type: EXPERIMENTAL
Intervention: E6011 (0.0006-10 mg/kg)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 29247083

Group type: EXPERIMENTAL
Intervention: Allen Carr's Easyway programme
Number of subjects: 0

Group type: COMPARATOR
Intervention: 1-1 counselling service via the National Health Service
Number of subjects: 0
Study: 26425688

Group type: EXPERIMENTAL
Intervention: Adjuvant 5-fluorouracil (5FU)
Number of subjects: 572
Study: 23478870

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral group intervention for children (child-only intervention)
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral group intervention for children (parent-child intervention)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 194
Study: 21440702

Group type: EXPERIMENTAL
Intervention: Constraint‐Induced Movement Therapy (CIMT)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Bimanual training
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: CIMT
Number of subjects: 64
Study: 19567922

Group type: EXPERIMENTAL
Intervention: CHO supplemented
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 16941239

Group type: EXPERIMENTAL
Intervention: PRT with the recommended therapist voice (RV)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: PRT with conversational therapist voice (CV)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Systematic self-relaxation (SR)
Number of subjects: 48

Group type: COMPARATOR
Intervention: No treatment control (NT)
Number of subjects: 48
Study: 16281522

Group type: EXPERIMENTAL
Intervention: Methanthelinium bromide 50 mg orally twice daily for 4 weeks
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Methanthelinium bromide
Number of subjects: 41
Study: 11136321

Group type: EXPERIMENTAL
Intervention: High-risk adenomas
Number of subjects: 442
Study: 9289631

Group type: EXPERIMENTAL
Intervention: 20% sucralfate suspension
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 1 gram sucralfate chewable tablets
Number of subjects: 28
Study: 8214949

Group type: EXPERIMENTAL
Intervention: Flurbiprofen (prostaglandin synthetase inhibitor)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 3612641

Group type: EXPERIMENTAL
Intervention: Multivitamin/multimineral with 65 mg of iron
Number of subjects: 42

Group type: COMPARATOR
Intervention: Multivitamin without iron
Number of subjects: 42
Study: 29792908

Group type: EXPERIMENTAL
Intervention: 200 mg caffeine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 27856807

Group type: EXPERIMENTAL
Intervention: High-resistance-moderate-endurance (Re)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Moderate-endurance-moderate-resistance (re)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Moderate-resistance-high-endurance (rE)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: All training modalities (combined)
Number of subjects: 80
Study: 26263033

Group type: EXPERIMENTAL
Intervention: NPPV (inspiratory/expiratory positive airway pressure of 28.2 ± 2.8 / 5.5 ± 1.5 mbar)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Supplemental oxygen (2.4 ± 0.7 L/min)
Number of subjects: 15
Study: 23857313

Group type: EXPERIMENTAL
Intervention: Dichoptic treatment combined with visual cortex direct current stimulation
Number of subjects: 16

Group type: COMPARATOR
Intervention: Dichoptic treatment alone
Number of subjects: 16
Study: 21149659

Group type: EXPERIMENTAL
Intervention: Docetaxel plus trastuzumab
Number of subjects: 284

Group type: COMPARATOR
Intervention: Vinorelbine plus trastuzumab
Number of subjects: 284
Study: 19213337

Group type: EXPERIMENTAL
Intervention: Chinese recipe for RSRCC
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 64
Study: 16339469

Group type: EXPERIMENTAL
Intervention: Task-specific training with trunk restraint (TR)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 30
Study: 14564317

Group type: EXPERIMENTAL
Intervention: Q-wave MI
Number of subjects: 13100

Group type: EXPERIMENTAL
Intervention: Non-Q-wave MI
Number of subjects: 13100

Group type: EXPERIMENTAL
Intervention: Q-wave MI with complete ST-segment resolution
Number of subjects: 13100

Group type: EXPERIMENTAL
Intervention: Q-wave MI with partial ST-segment resolution
Number of subjects: 13100

Group type: EXPERIMENTAL
Intervention: Q-wave MI with no ST-segment resolution
Number of subjects: 13100

Group type: EXPERIMENTAL
Intervention: Non-Q-wave MI with complete ST-segment resolution
Number of subjects: 13100

Group type: EXPERIMENTAL
Intervention: Non-Q-wave MI with partial ST-segment resolution
Number of subjects: 13100

Group type: EXPERIMENTAL
Intervention: Non-Q-wave MI with no ST-segment resolution
Number of subjects: 13100
Study: 11113042

Group type: EXPERIMENTAL
Intervention: Primary stenting
Number of subjects: 620

Group type: COMPARATOR
Intervention: Balloon angioplasty
Number of subjects: 620

Group type: EXPERIMENTAL
Intervention: Balloon angioplasty followed by stenting (after optimization)
Number of subjects: 620

Group type: COMPARATOR
Intervention: Balloon angioplasty without stenting (after optimization)
Number of subjects: 620

Group type: COMPARATOR
Intervention: Provisional angioplasty
Number of subjects: 620
Study: 8853223

Group type: EXPERIMENTAL
Intervention: ondansetron 0.25 mg bd
Number of subjects: 111

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 111
Study: 1740401

Group type: EXPERIMENTAL
Intervention: Instantaneous rise time at 60 dB
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Instantaneous rise time at 95 dB
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 50 ms rise time at 60 dB
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 50 ms rise time at 95 dB
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: All groups (combined analysis)
Number of subjects: 120
Study: 6096517

Group type: EXPERIMENTAL
Intervention: VP-16-213
Number of subjects: 165
Study: 29544506

Group type: EXPERIMENTAL
Intervention: Responsive Parenting (RP) intervention
Number of subjects: 279
Study: 27094920

Group type: EXPERIMENTAL
Intervention: High social status position (HIGH)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Low social status position (LOW)
Number of subjects: 9
Study: 25342704

Group type: EXPERIMENTAL
Intervention: High protein (HP) beverage (1.5 g/100 ml)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Low protein (LP) beverage (0.75 g/100 ml)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control (CON) beverage (0 g/100 ml)
Number of subjects: 13
Study: 23576048

Group type: EXPERIMENTAL
Intervention: Casein (30 g, 15N-labeled)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Whey proteins (30 g)
Number of subjects: 13
Study: 19924001

Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stent (Xience V)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Bare metal stent (Multilink Vision)
Number of subjects: 213
Study: 19035944

Group type: EXPERIMENTAL
Intervention: Routine use of episiotomy
Number of subjects: 200

Group type: COMPARATOR
Intervention: Restrictive use of episiotomy
Number of subjects: 200
Study: 16810594

Group type: EXPERIMENTAL
Intervention: V-system
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional duodenoscope
Number of subjects: 50
Study: 12642251

Group type: EXPERIMENTAL
Intervention: Dexamethasone sodium phosphate (40 mA-minutes)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 199
Study: 11118468

Group type: EXPERIMENTAL
Intervention: myeloablative chemoradiotherapy with autologous purged bone marrow rescue
Number of subjects: 466

Group type: EXPERIMENTAL
Intervention: Positive blood immunocytology at diagnosis
Number of subjects: 466
Study: 9188997

Group type: COMPARATOR
Intervention: 0.2 mg/kg midazolam
Number of subjects: 17

Group type: COMPARATOR
Intervention: 0.3 mg/kg midazolam
Number of subjects: 17
Study: 1540363

Group type: EXPERIMENTAL
Intervention: Heated Humidifier (HH)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Heat and Moisture Exchanger (HME)
Number of subjects: 51

Group type: COMPARATOR
Intervention: No warming device (Control)
Number of subjects: 51